University of Minnesota’s COVID-OUT Investigation into Ivermectin—A Potential Early-Onset Treatment for Some COVID-19 Cases

University of Minnesota’s COVID-OUT Investigation into Ivermectin—A Potential Early Onset Treatment for Some COVID-19 Cases

In May, TrialSite introduced one of the largest ivermectin-based studies in the United States—the “COVID-OUT” study led by principal investigator Carolyn Bramante, MD, University of Minnesota. The study was initially funded by UnitedHealthcare’s OptumLabs, a division of one of America’s largest health insurers, and the Parsemus Foundation. More recently, additional funds helped the study expand—via a $1 million grant from the Rainwater Charitable Foundation and a $500,000 grant from Fast Grants. Not only did these funds help to expand the study, but the investigation is one of the first randomized clinical trials for COVID-19 to include pregnant women. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), is on the record that what’s needed now are orally administered antiviral treatments to address COVID-19 infection early on as the vast majority of cases are mild-to-moderate in symptom. The key to managing this pandemic, in addition to safe and effective vaccines and sound, situational, and contextual public health policy, are low-cost treatments that can reduce the likelihood of infection progression. About 90% of ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee